A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308521 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Inga Petersen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: alpha-Synuclein. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Parkinsonfonden, Swedish Research Council, Åhlén-stiftelsen.
Abstract (Originalsprache)
The aggregation of α-Synuclein (αSyn) is strongly linked to neuronal death in Parkinson’s disease and other synucleinopathies. The spreading of aggregated αSyn between neurons is at least partly dependent on electrostatic interactions between positively charged stretches on αSyn fibrils and the negatively charged heparan sulphate proteoglycans on the cell surface. To date there is still no therapeutic option available that could halt the progression of Parkinson’s disease and one of the major limitations is likely the relatively low proportion of αSyn aggregates accessible to drugs in the extracellular space. Here, we investigated whether a negatively charged peptide tail fused to the αSyn aggregate-specific antibodies SynO2 and 9E4 could enhance the antibodies’ avidity to αSyn aggregates in order to improve their potential therapeutic effect through inhibiting cell-to-cell spreading and enhancing the clearance of extracellular aggregates. We performed ELISAs to test the avidity to αSyn aggregates of both monovalent and bivalent antibody formats with and without the peptide tail. Our results show that the addition of the negatively charged peptide tail decreased the binding strength of both antibodies to αSyn aggregates at physiological salt conditions, which can likely be explained by intermolecular repulsions between the tail and the negatively charged C-terminus of αSyn. Additionally, the tail might interact with the paratopes of the SynO2 antibody abolishing its binding to αSyn aggregates. Conclusively, our peptide tail did not fulfil the required characteristics to improve the antibodies’ binding to αSyn aggregates. Fine-tuning the design of the peptide tail to avoid its interaction with the antibodies’ CDR and to better mimic relevant characteristics of heparan sulphates for αSyn aggregate binding may help overcome the limitations observed in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
- Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
- Department of Physics, Chemistry and Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Linköping University, Linköping, Sweden.
ORCID-Profile: Anders Hofer, Greta Hultqvist
Förderung
- Parkinsonfonden
- Swedish Research Council
- Åhlén-stiftelsen
- Jeanssons Stiftelser
- Magnus Bergvalls Stiftelse
- VINNOVA
- Alzheimerfonden
- Stiftelsen Olle Engkvist Byggmästare
Zitieren
APA
Petersen, I., Godec, A., Ranjbarian, F., Hofer, A., Mirabello, C., & Hultqvist, G. (2024). A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils. PLOS ONE. https://doi.org/10.1371/journal.pone.0308521
Vancouver
Petersen I, Godec A, Ranjbarian F, Hofer A, Mirabello C, Hultqvist G. A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils. PLOS ONE. 2024. doi:10.1371/journal.pone.0308521
BibTeX
@article{Petersen2024,
author = {Petersen, Inga and Godec, Ana and Ranjbarian, Farahnaz and Hofer, Anders and Mirabello, Claudio and Hultqvist, Greta},
title = {A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308521}
}
EUVIMED